F605 in Virginia. Pick another state for the same tag.
Against expectation — 2025
Virginia cites F605 less often than its own record predicts
Versus expected share0.76×
0.76 times the national share — cited less often here than elsewhere.
Share of Virginia citations0.54%
Of every deficiency written in Virginia in 2025, this is the portion that was F605.
Virginia0.54%
National0.70%
Share of all citations that were F605.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Virginia surveyors wrote
F605 findings written in Virginia, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedJune 17, 2026
Based on staff interview, facility document review, and clinical record review, the facility staff failed to ensure residents were free from unnecessary psychotropic medications for two of 35 residents in the survey sample, Residents #17, and #74. The findings include:
1. For Resident #17 (R17), the facility staff failed to address a GDR (Gradual Dose Reduction) for the antidepressant medication Paxil and the antidepressant medication Trazadone.
A review of R17's clinical record revealed the following physician's orders:
-3/28/25-Paxil 40mg (milligrams). One tablet at bedtime for major depressive disorder.
-6/11/25-Trazadone 50mg. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction